Postpartum fibroid degeneration associated with elevated procalcitonin levels
Author:
Thakkar Meera Madhusudan1, Kaawar Fawzi2, Dinglas Cheryl1
Affiliation:
1. Department of Obstetrics and Gynecology , Mount Sinai South Nassau Hospital , Oceanside , NY , USA 2. School of Medicine , Ross University , Bridgetown , Barbados
Abstract
Abstract
Objectives
To describe a novel presentation of severely elevated procalcitonin (PCT) levels associated with postpartum fibroid degeneration.
Case presentation
We report a case of a 34-year-old woman with multiple large fibroids who was found to have fevers and a severely elevated PCT level of 34.03 ng/mL 2 days postpartum. MRI revealed carneous degeneration of her fibroids, and other etiologies such as infection were ruled out. She was successfully treated with the use of intravenous non-steroidal anti-inflammatory drugs and antibiotics, as a precaution. This report indicates procalcitonin may be elevated secondary to the inflammatory state caused by degenerating fibroids. Informed consent was obtained from all individuals included in this study.
Conclusions
Uterine leiomyomas, or fibroids, are tumors of the female reproductive tract affecting anywhere from 20–40% of women. One known complication of fibroids is degeneration, when the fibroid can infarct due to a decrease in blood supply. This can cause an inflammatory state with the release of multiple inflammatory markers. During pregnancy, routine markers such as white blood cell counts may be unreliable. Other markers such as procalcitonin are not well-studied in pregnancy. This case provides practitioners an example where the marker procalcitonin can be used to more accurately assess an inflammatory state during pregnancy. It also provides alterative diagnoses in the workup of postpartum fever.
Publisher
Walter de Gruyter GmbH
Subject
Obstetrics and Gynecology,Embryology,Pediatrics, Perinatology and Child Health
Reference10 articles.
1. Agarwal, R, Priyadarshini, P, Mehndiratta, M. Serum procalcitonin in pregnancy-associated sepsis: a case control study. S Afr J Obstet Gynaecol 2019;25:15–9. https://doi.org/10.7196/sajog.1397. 2. Schneider, HG, Lam, QT. Procalcitonin for the clinical laboratory: a review. Pathology 2007;39:383–90. https://doi.org/10.1080/00313020701444564. 3. Klingbeil, KD, Polcari, AM, Azab, B, Francheschi, D. Large, extra-abdominal leiomyoma of the round ligament with carneous degeneration. BMJ Case Rep 2017;2017:1–5. https://doi.org/10.1136/bcr-2017-222454. 4. Cunningham, GF, Leveno, KJ, Bloom, SL, Dashe, JS, Hoffman, BL, Casey, BM, et al.. Neoplastic disorders. In: Williams obstetrics, 25th ed. New York: McGraw-Hill; 2018:1195–7 pp. 5. Lee, HJ, Norwitz, ER, Shaw, J. Contemporary management of fibroids in pregnancy. Rev Obstet Gynecol 2010;3:20–7.
|
|